182 results about "Digestive cancers" patented technology

The invention provides a processing process of a spicy cabbage product. The processing process comprises the following steps: selecting present-year cabbages which have large sizes, are solid and do not rot and go bad; cutting the cabbages in half and washing; sterilizing with 200pm sodium hypochlorite for 5 minutes; removing core parts of cabbages and cutting the cabbages without the cores into strips being 3cm wide by a machine; washing the cabbages by an air blowing type vegetable washing machine; selecting raw materials meeting the specification, scattering refined salt being about 10% of the weight of the cabbages, and injecting 3% salt water being 20% of the weight of the cabbages; sterilizing with the 200pm sodium hypochlorite for 5 minutes; washing and dehydrating for 60 seconds by using a dehydrating machine; stirring the dehydrated raw materials and flavoring sauce in a ratio of 4 to 1; and metering and canning every 293g-295g of the mixed raw materials. The pickled vegetables have abundant nutrition and have an antibacterial effect along fermentation; furthermore, the pickled vegetables can prevent acid poisoning caused by acidification of blood due to eating of excessive meat or acidic foods; the pickled vegetables also can be used for preventing adult diseases and also have the effect of preventing obesity, hypertension, diabetes mellitus and digestive system cancers; and furthermore, the pickled vegetables also have the effect of clearing stomachs and intestines due to the compounding of juice of the vegetables, the refined salt and the like.

The CD133 marker has been found to be diagnostic of tumourigenic digestive system cancer, particularly malignant colorectal cancers. Tests to show such cells and uses for such cells are disclosed.

The invention relates to a sophocarpidine pH/ magnetic dual-sensitive hydrogel globule which is orally administrated and is used for treating digestive cancers and the preparation method of the sophocarpidine pH/ magnetic dual-sensitive hydrogel globule. The preparation method comprises the steps of: adding 0.3 to 0.7 g of CaCl to chitosan acetum; agitating to dissolve CaCl; preparing a 1.5 to 2.5% sodium alginate solution based on the mass to the volume concentration; weighing a proper amount of sophocarpidine and a proper amount of Fe3O4 nanoparticle respectively, and adding to the sodium alginate solution to obtain a suspension containing the sophocarpidine, the Fe3O4 nanoparticle and the sodium alginate; and weighing the suspension containing the sophocarpidine, the Fe3O4 nanoparticle and the sodium alginate, and dropping to the mixed solution of the chitosan and CaCl2 for crosslinking, and then filtering, washing, and then placing and naturally drying at room temperature so as to obtain the sophocarpidine pH/ magnetic dual sensitive hydrogel globule.

An enzyme having an activity of transferring N-acetylglucosamine to the non-reducing end of a Gal β1-4Glc or Gal β1-4GlcNAc-group via a β-1,3 bond; a nucleic acid encoding the same; and a method of diagnosing cancer and/or tumor, in particular, digestive cancer and/or tumor using the expression dose of a gene of the above enzyme as an indication. A gene of a novel enzyme having an activity of transferring N-acetylglucosamine to the non-reducing end of a Gal β1-4Glc or Gal β1-4GlcNAc-group via a β-1,3 bond is cloned from human stomach cells and its base sequence is determined. Then this enzyme is expressed. Since this enzyme is scarcely or never produced in cancer and/or tumor, in particular, digestive cancer and/or tumor cells, cancer and/or tumor can be diagnosed with the use of the expression of the enzyme gene as an indication.

The invention relates to a Chinese medicament for preventing and treating digestive tract cancer and process for preparation, wherein the medicament is prepared from astragalus root, green tangerine orange peel, banksia rose, linaloe, clove, zedoary, burred tuber, Ligusticum wallichii, pinellia tuber, white mustard seed, euphorbia helioscopia, radical lobelia, barbat skullcap, oldenlandia, selfheal, dried body of ground beetle, leeches and water.

The present inventors have surprisingly found that a deoxyhypusine synthase (DHPS) gene, which was previously reported to correlate with prostate cancer and cervical cancer, is highly responsive to arteriosclerosis or digestive system cancer, whereby the gene can be used as a desired marker for arteriosclerosis or digestive system cancer. The present invention has been accomplished on the basis of this finding. Specifically, the present invention provides a method for determining arteriosclerosis or digestive system cancer, which method includes detecting expression of a deoxyhypusine synthase gene in a test sample (preferably a blood sample), and determining arteriosclerosis or digestive system cancer of a test subject from which the test sample has been obtained, on the basis of an increase in the gene expression as an index.

The invention relates to a formula and a preparation method of a Hui nationality traditional Chinese medicinal Radix Astragali and Sonchus oleraceus L. root stomach cancer treatment pill. The pill is a green high-tech Chinese herbal medicine used for treating late stomach cancer, especially late stomach cancer which cannot be operated due to various reasons. The pill is a traditional Chinese medicinal pill prepared through the following steps: mixing of Radix Astragali, Radix Codonopsis, Sonchus oleraceus L. root, Cortex Acanthopanacis, Malaytea Scurfpea Fruit, Polygonatum sibiricum and other Chinese herbal medicines in proportion, water adding, decoction, extraction, concentration and pill preparation. The pill is mainly used for treating the stomach cancer, and also is used for treating the throat cancer, the esophagus cancer, the cardiac cancer, the colorectal cancer and other digestive system cancers. The pill has the characteristics of small medicine variety quantity and moderate dosage, and all the medicines are proved by modern medical science pharmacological experiments to be suitable for treating the cancers.

The invention relates to a formula and a preparation method of a Hui traditional Chinese medicine hedyotis diffusa willd anti-esophageal cancer oral liquid. According to the present invention, the Hui traditional Chinese medicine hedyotis diffusa willd anti-esophageal cancer oral liquid is the green high-tech Chinese herb for esophageal cancer treatment; and hedyotis diffusa willd, scutellaria barbata, panax notoginseng and other Chinese herbs are mixed according to a certain ratio, water is added, and decoction, extraction and concentration are performed to obtain the traditional Chinese medicine oral liquid; and the Hui traditional Chinese medicine hedyotis diffusa willd anti-esophageal cancer oral liquid mainly treats esophageal cancer, can further treat throat cancer, stomach cancer, large intestine cancer and other digestive system cancers, and has characteristics of moderate components and moderate doses, wherein the modern medical pharmacology experiment results prove that the selected medicines can treat cancers, and the body functions are fundamentally improved and the cell cancerization is prevented in the low cost manner so as to recover the health body.

The invention relates to a Dendrobium huoshanense polysaccharide with an anti-digestive system cancer effect. The polysaccharide is an acetylated glucomannan having a novel structure and uniform components and obtained from the stems of Dendrobium huoshanense, the relative molecular mass is 2.59 * 10<5> Da, the repeating structural unit of the polysaccharide is formed by three sugar residues whichare -4)-beta-D-glucopyranose-(1-, -4)-beta-D-mannopyranose-(1- and -4)-3-oacetyl-beta-D-mannopyranose-(1-, and a molar ratio of glucose to mannose is 1:3. The Dendrobium huoshanense polysaccharide with the anti-digestive system cancer effect is prepared by combining a pectase and high temperature-resistant amylase hydrolysis process with an anion and cation exchange resin purification process, sothe pollution of pectin and starch is effectively avoided, and the removal of impurities such as proteins and salts is achieved; process conditions are mild, and the prepared polysaccharide has a high purity; and the Dendrobium huoshanense polysaccharide of the invention has small side effects, has resistance to digestive system cancers such as gastric cancer, colorectal cancer and liver cancer,and can be used for the development of new anti-digestive cancer drugs.

The invention provides a formula and preparation method of Hui-nationality traditional Chinese medicine aralia root bark granules for treating gastric cancer. The medicine is a green and high-tech traditional Chinese medicine for treating advanced gastric cancer, especially the advanced gastric cancer which cannot be subjected to a surgery due to various reasons. The Hui-nationality traditional Chinese medicine aralia root bark granules are traditional Chinese medicine granules prepared by mixing traditional Chinese medicines including aralia root bark, rhizoma curcumae, herba sarcandrae, fiveleaf akebia fruit, seaweed, cortex ailanthi, aloe and the like at a certain ratio, adding water and decocting, extracting, concentrating and granulating. The Hui-nationality traditional Chinese medicine aralia root bark granules are used for mainly treating the gastric cancer and can also be used for treating digestive system cancers including pharyngolaryngeal cancer, esophageal cancer, cardiac cancer, colorectal cancer and the like. The Hui-nationality traditional Chinese medicine aralia root bark granules have the characteristics of a few of medicines and moderate dosage; modern medicine pharmacological experiments of most of the selected medicines show that the medicines can be used for treating the cancer.

The invention discloses a health-care ginseng papaya lily glutinous rice dumpling. The dumpling is composed of the following ingredients, by weight: 93 to 100 parts of glutinous rice, 10 to 12 parts of hawthorn fruit powder, 36 to 46 parts of papaya, 1 to 2 parts of heartleaf houttuynia leaves, 3 to 4 parts of marsh marigold herbs, 1 to 3 parts of Japanese thistle roots, 8 to 10 parts of apple juice, 2 to 3 parts of polygonati rhizomes, 1 to 2 parts of common rush, 2 to 3 parts of glossy privet fruits, 1 to 2 parts of vegetable sponge of luffa, 3 to 4 parts of tree peony barks, 2 to 3 parts of gynostemma pentaphylla, 2 to 3 parts of pseudo-ginseng roots, 1 to 2 parts of hollyhock roots, 2 to 3 parts of licorice, and the balance being proper amount of excipients. The dumpling uses a mixture of Chinese herbal medicine extract and mulberry juice to improve the taste of a conventional dumpling wrapper produced from only glutinous rice and water, and makes the dumpling wrapper more nutrient. The papaya in the dumpling can help digestion, prevent and cure constipation, and prevent digestive cancer. The heartleaf houttuynia leaves, the glossy privet fruits, the gynostemma pentaphylla and the marsh marigold herbs all have some cancer-preventing effects, can be eaten frequently without any toxic and side effects, and can improve human immunity. Thus the dumpling is especially suitable for sub-health population to eat.

The invention relates to a formula of Hui nationality traditional Chinese medicine astragalus membranaceus root stomach cancer-dispersing granules and a preparation method thereof. The granules are Chinese herbal medicine with environmental friendlessness as well as high science and technology for treating stomach cancer, especially stomach cancer with difficult operation at a late period due to various reasons; the Hui nationality traditional Chinese medicine astragalus membranaceus root stomach cancer-dispersing granules comprise the raw materials of astragalus membranaceus, radix Codonopsis, bitter herbs root, cortex acanthopanacis, Psoralea corylifolia and polygonatum rhizome according to a certain proportion, and the preparation method comprises the steps of mixing, adding water, decocting, extracting, concentrating, and granulating; and the astragalus membranaceus root stomach cancer-dispersing granules are used for mainly treating digestive system cancers such as stomach cancer, throat cancer, esophagus cancer, cardia cancer, and colorectal cancer. The astragalus membranaceus root stomach cancer-dispersing granules have the characteristics of moderate flavor and dosage, and the selected raw materials can be used for treating cancer through modern medical pharmacology experiments.

Ligands of nuclear receptors PPAR's (peroxisome proliferator-activated receptors) which are compounds selected from the group consisting of ascofuranone; and ascofuranone homologs and ascochlorin homologs having at least an orcyl aldehyde moiety wherein the hydrogen atom(s) of the hydroxyl group(s) at the 2-position and/or the 4-position of the orcyl aldehyde moiety are substituted by C1-15 alkyl, C1-15 alkenyl, CH2COOH, CH2COO(C1-15 alkyl), C(C=O)(C1-15 alkyl), C(=O)(CH2)1-15COOH, nicotinoyl, isonicotinoyl, etc. These ligands are usable in preventing and/or treating diabetes; hypertension or cerebrovascular disorders; arteriosclerosis; complications of diabetes; chronic inflammation; cachexia; digestive cancers, etc.

Cancer treatment methods comprising a step of applying remote conditioning to the cancer subject, for example remote ischemic conditioning via several episodes of short-term limb occlusion. Upregulation and release of remote conditioning substances such as microRNA 144/451 cluster endogenously caused by remote conditioning may be beneficial in reducing the growth and proliferation of malignant cells. Remote conditioning may also be beneficial when combined with chemotherapy or radiation therapy as it may improve survival of healthy surrounding tissues and minimize side effects of these known cancer treatments. Remote conditioning may be non-invasively applied by a medical professional or self-applied by the cancer subject at home using an automatic device. The novel cancer treatment methods may be used for lung cancers, liver cancers, colorectal cancers, digestive cancers and other cancers.

The invention provides a Chinese medicine composition consisting of Chinese medicinal materials such as ginseng, red salt and radix pseudo-ginseng. The Chinese medicine composition has the efficacies of benefiting qi and removing blood stasis, as well as detoxicating and resolving a mass, and the effects of stable medicine properties, anti-inflammation and detumescence, analgesia and circulation improvement, and can supplement part of trace elements for a human body, improve body immunity, and be used for treating digestive system diseases, especially digestive system cancer.

The invention discloses a marker for digestive system cancer detection and application of the marker. The marker is a combination of Vimentin and CD11b. The expression conditions of the marker in different individuals show the special phenomena of ultrahigh expression in peripheral blood of a cancer patient, higher expression in peripheral blood of an early cancer patient and almost no expressionin peripheral blood of a healthy volunteer, and the marker can be used for digestive system tumor early screening and solid tumor treatment dominant population including gastric cancer and evaluatingthe treatment effect.

The invention relates to Hui nationality traditional Chinese medicine Chinese caterpillar fungus pills for treating lung cancer and a preparation method thereof. The traditional Chinese medicine Chinese caterpillar fungus pills for treating lung cancer are a Chinese herbal medicine product having advantages of environmental protection as well as high science and technology, which take Cordyceps sinensis, Chinese aralia, oyster, laminaria japonica, Herba Pteridis multifidae and Salvia chinensis according to a certain proportion, the above Chinese herbal medicines are mixed, water is added in a mixture, the mixture is decocted, extracted, concentrated, and pelleted to obtain the product. The traditional Chinese medicine Chinese caterpillar fungus pills are mainly used for treating lung cancer, and treating digestive system cancers such as pharyngolaryngeal cancer, stomach cancer and colorectal cancer, and have the characteristics of moderate flavor and dosage, the selected Chinese herbal medicines are proved for treating cancer by modern medical pharmacological experiments, with low cost, the body function can be fundamentally improved, condition deterioration is prevented, and body health is recovered.

A diagnostic marker is composed of particles that have a diameter of from 1 nm to 100 μm, the particles possessing on their surfaces a site that has a high specific bonding ability to a specific antigen residing on the mucosa of digestive cancers and a site that has a low bonding ability to the mucosa of digestive organs, and further incorporating an identification material.

The invention provides a peptidoglycan-zinc chelate for preventing and treating tumor and relates to the fields of medicine, food, feed adding, biochemistry and the like, in particular to the field of medicine. Single peptidoglycan is limited on the prevention and treatment effect on tumor, and the extraction process of the peptidoglycan is tedious, long in time consumption and high in dangerousness. The effect on prevention and treatment of tumor of the peptidoglycan-zinc chelate is higher than that of the peptidoglycan, especially on digestive system cancer, and extraction and synthesis processes of the peptidoglycan-zinc chelate are simpler, more convenient, more efficient and safer compared with extraction of single peptidoglycan; single zinc ions are not absorbed by the human body easily and have side effects. According to the peptidoglycan-zinc chelate and a preparation method thereof, polymer of polypeptide and sugar is used for the first time to change the form of zinc, inorganic zinc ions are converted to organozinc compounds, absorption of zinc by the human body can be more efficient, human body immunity is improved, and the effect of preventing and treating cancer of peptidoglycan can be further assisted; the peptidoglycan-zinc chelate has inhibition and prevention functions on multiple types of cancer, can improve human body immunity and further has a high-efficiency zinc-supplementation effect.

The invention provides a formula and preparation method of Hui-nationality traditional Chinese medicine rhizoma curcumae pills for treating gastric cancer. The medicine is a green and high-tech traditional Chinese medicine for treating advanced gastric cancer, especially the advanced gastric cancer which cannot be operated on due to various reasons. The Hui-nationality traditional Chinese medicine rhizoma curcumae pills are traditional Chinese medicine pills prepared by mixing traditional Chinese medicines including rhizoma curcumae, fiveleaf gynostemma herb, herba sarcandrae, radix linderae, herba pteridis multifidae, Chinese lobelia herb and the like at a certain ratio, adding water and decocting, extracting, concentrating and pilling. The Hui-nationality traditional Chinese medicine rhizoma curcumae pills are used for mainly treating the gastric cancer and can also be used for treating digestive system cancers including pharyngolaryngeal cancer, esophageal cancer, cardiac cancer, colorectal cancer and the like; the Hui-nationality traditional Chinese medicine rhizoma curcumae pills have the characteristics of a few of medicines and moderate dosage; modern medicine pharmacological experiments of most of the selected medicines show that the medicines can be used for treating the cancer.

The invention detailedly describes a formula and a preparation method of a rhizoma zedoariae esophageal cancer-treating tablet as a traditional Chinese medicine of the Hui nationality. The rhizoma zedoariae esophageal cancer-treating tablet is a green high-tech Chinese herbal medicine for treating an esophageal cancer. The rhizoma zedoariae esophageal cancer-treating tablet is a traditional Chinese medicine oral liquid prepared by mixing subprostrate sophora, rhizoma zedoariae, herba sarcandrae, circium japonicum and other Chinese herbal medicines according to a certain proportion, adding water, decocting, extracting, concentrating and tabletting, is mainly used for treating the esophageal cancer and has the effect of treating a throat cancer, a gastric cancer and a colorectal cancer and other digestive system cancers. The rhizoma zedoariae esophageal cancer-treating tablet described by the invention has the characteristic of being moderate in medicine taste and dosage; the selected medicines are proved to be able to treat the cancers by a modern pharmacological experiment; the rhizoma zedoariae esophageal cancer-treating tablet fundamentally improves body functions at a low cost, and prevents and treats cancer cells, thereby restoring body health.

The invention discloses a formula of Hui nationality traditional Chinese medicine particles for treating esophageal cancer and a preparation method of the Hui nationality traditional Chinese medicine particles. The Hui nationality traditional Chinese medicine particles are eco-friendly high-tech traditional Chinese medicines for treating esophageal cancer and are prepared from traditional Chinese medicines such as radix sophorae tonkinensis, root-bark of Araiia chinensis L., smoked plum, semen cuscutae and the like according to a certain proportion through material blending, water decoction, extraction, concentration and granulation. The Hui nationality traditional Chinese medicine particles are mainly used for treating esophageal cancer and also can treat digestive system cancers such as pharyngolaryngeal cancer, gastric cancer and colorectal cancer. The Hui nationality traditional Chinese medicine particles have a moderate taste and a moderate dose. The selected traditional Chinese medicines are proved to be able to treat cancers by the modern medical pharmacology experiments, have a very low price, can prevent and treat cell cancerization and can restore health.